Subscribe to our Newsletters !!
Infections pose an everpresent threat to society a
Biotech Fluidics has introduced a durable dual sta
A new COVID-19 variant, BA.3.2, informally called
The sustained tensions between Iran and the United
For a number of years now, healthcare systems glob
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-lo
Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German spouse BioNTech and raised its full-year profit forecast.
The company said it expects total 2021 earnings of between $59.4 billion and $61.4 billion.
The vaccine was among the first to be authorized for emergency use in the USA and various other countries, and analysts have forecast billions in sales.
In the fourth quarter, the vaccine brought in sales of $154 million, below expectations of $462 million, according to consensus estimates compiled by brokerage Mizuho.
The company now expects full-year adjusted earnings of $3.10 to $3.20 per share, up from its prior forecast of $3 to $3.10 per share.
